Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
about
Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report.Antiphospholipid Antibodies and Associated Clinical Manifestations.Antiphospholipid antibody associated thrombosis: a consensus for treatment?Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.
P2860
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@ast
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@en
type
label
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@ast
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@en
prefLabel
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@ast
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@en
P2860
P1433
P1476
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
@en
P2093
P2860
P304
P356
10.1177/096120339400300419
P577
1994-08-01T00:00:00Z